PerfusionPub Date : 2024-04-27DOI: 10.1177/02676591241250288
John R Priest, David Hebert, Camille Jutras
{"title":"Anticoagulation during extracorporeal membrane oxygenation: A narrative review","authors":"John R Priest, David Hebert, Camille Jutras","doi":"10.1177/02676591241250288","DOIUrl":"https://doi.org/10.1177/02676591241250288","url":null,"abstract":"Extracorporeal Membrane Oxygenation (ECMO) is a technology that offers organ support for critically ill patients with respiratory and/or cardiac failure. Despite improvements in recent years in technology and the biocompatibility of circuits, patients on ECMO remain at high risk of hematologic complications, such as bleeding or thrombosis. Anticoagulation is required in most cases to limit the risk of clotting, but questions persist regarding the optimal anticoagulation strategy. More precisely, there is still debate around the best anticoagulation agent and monitoring tools as well as on the transfusion thresholds and appropriate corrective measures when faced with complications. This narrative review provides an overview of hemostasis on ECMO and the impact of circuit size and coating. The benefits and downsides of unfractionated heparin (UHF) and Direct Thrombin Inhibitors (DTIs) as anticoagulation agents are reviewed. Finally, commonly available coagulation tests (activated clotting time, activated partial thrombin time, anti-Xa, and viscoelastic tests) and their limitations are addressed. In conclusion, future research is needed to determine the best anticoagulation strategy for patients on ECMO.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140812413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-26DOI: 10.1177/02676591241249936
Chandler Causey, Elisabeth Jones, Michaela Califano, Abby Curtis, Justin Muir, William Dauch, Laura Dell'Aiera, David C. Fitzgerald
{"title":"Advances in remote and cloud-based simulation through web conferencing platforms.","authors":"Chandler Causey, Elisabeth Jones, Michaela Califano, Abby Curtis, Justin Muir, William Dauch, Laura Dell'Aiera, David C. Fitzgerald","doi":"10.1177/02676591241249936","DOIUrl":"https://doi.org/10.1177/02676591241249936","url":null,"abstract":"INTRODUCTION\u0000Simulation-based learning has become an essential element in entry-level perfusion education. While the use of simulation has been demonstrated to improve patient outcomes, few institutions possess the budgetary resources to build and maintain a high-fidelity simulation environment. This project aims to identify novel uses of web conferencing platforms to support in-person, remote, and virtual simulation exercises.\u0000\u0000\u0000METHODS\u0000The Zoom Virtual Meeting platform (Zoom Video Communications, Inc.) was incorporated into the perfusion simulation curriculum at the Medical University of South Carolina CVP Program. Among the observed benefits of incorporating meeting platform software included high-definition audio/visual outputs and recording capabilities, 3-D remote simulation, remote simulation proctoring, and classroom-based learning. Additional Zoom features included remote controlled screen access and sharing, annotations, and break-out rooms and activities.\u0000\u0000\u0000CONCLUSION\u0000The combination of high-fidelity simulation with virtual and remote features may enhance the learning experience in healthcare education. Future developments in technology and software, simulation education, and instructions through virtual/remote learning may provide a pathway for the future of cardiovascular perfusion education.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"6 5","pages":"2676591241249936"},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140653081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-23DOI: 10.1177/02676591241240377
Marta Cucchi, Silvia Mariani, Michal J Kawczynski, E. Shkurka, Fabio Ius, G. Comentale, A. Hoskote, R. Lorusso
{"title":"Individual patient data meta-analysis on awake pediatric extracorporeal life support: Feasibility and safety of analgesia, sedation and respiratory support weaning, and physiotherapy.","authors":"Marta Cucchi, Silvia Mariani, Michal J Kawczynski, E. Shkurka, Fabio Ius, G. Comentale, A. Hoskote, R. Lorusso","doi":"10.1177/02676591241240377","DOIUrl":"https://doi.org/10.1177/02676591241240377","url":null,"abstract":"OBJECTIVE\u0000Awake Extracorporeal Life Support (aECLS) with active mobilization has gained consensus over time, also within the pediatric community. This individual patient data (IPD) meta-analysis summarizes available evidence on pediatric aECLS, its feasibility, and safety regarding sedation weaning, extubation, and physiotherapy.\u0000\u0000\u0000METHODS\u0000PubMed/Medline and Cochrane Database were screened until February 2022. Articles reporting on children (≤18 years) undergoing aECLS were selected. IPD were requested, pooled in a single database, and analyzed using descriptive statistics. Primary outcome was survival to hospital discharge. Secondary outcomes included extubation during ECLS, physiotherapy performed, tracheostomy, and complications.\u0000\u0000\u0000RESULTS\u0000Nineteen articles and 65 patients (males:n = 30/59,50.8%) were included. Age ranged from 2 days to 17 years. ECLS configurations included veno-venous (n = 42/65, 64.6%), veno-arterial (n = 18/65, 27.7%) and other ECLS settings (n = 5/65, 7.7%). Exclusive neck cannulation was performed in 51/65 (78.5%) patients. Extubation or tracheostomy during ECLS was reported in 66.2% (n = 43/65) and 27.7% (n = 18/65) of patients, respectively. Physiotherapy was reported as unspecified physical activity (n = 34/63, 54%), mobilization in bed (n = 15/63, 23.8%), ambulation (n = 14/63, 22.2%). Complications were reported in 60.3% (n = 35/58) of patients, including hemorrhagic (36.2%), mechanical (17.2%), or pulmonary (17.2%) issues, and need for reintubation (15.5%). Survival at discharge was 81.5% (n = 53/65).\u0000\u0000\u0000CONCLUSION\u0000Awake ECLS strategy with active physiotherapy can be applied in children from neonatal age. Ambulation is also possible in selected cases. Complications related to such management were limited. Further studies on aECLS are needed to evaluate safety and efficacy of early physiotherapy and define patient selection.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"7 4","pages":"2676591241240377"},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140666607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-23DOI: 10.1177/02676591241237758
Ceri Jones, Marcus Taylor, Matthew Sperrin, Stuart W. Grant
{"title":"A systematic review of cardiac surgery clinical prediction models that include intra-operative variables","authors":"Ceri Jones, Marcus Taylor, Matthew Sperrin, Stuart W. Grant","doi":"10.1177/02676591241237758","DOIUrl":"https://doi.org/10.1177/02676591241237758","url":null,"abstract":"BackgroundMost cardiac surgery clinical prediction models (CPMs) are developed using pre-operative variables to predict post-operative outcomes. Some CPMs are developed with intra-operative variables, but none are widely used. The objective of this systematic review was to identify CPMs with intra-operative variables that predict short-term outcomes following adult cardiac surgery.MethodsOvid MEDLINE and EMBASE databases were searched from inception to December 2022, for studies developing a CPM with at least one intra-operative variable. Data were extracted using a critical appraisal framework and bias assessment tool. Model performance was analysed using discrimination and calibration measures.ResultsA total of 24 models were identified. Frequent predicted outcomes were acute kidney injury (9/24 studies) and peri-operative mortality (6/24 studies). Frequent pre-operative variables were age (18/24 studies) and creatinine/eGFR (18/24 studies). Common intra-operative variables were cardiopulmonary bypass time (16/24 studies) and transfusion (13/24 studies). Model discrimination was acceptable for all internally validated models (AUC 0.69-0.91). Calibration was poor (15/24 studies) or unreported (8/24 studies). Most CPMs were at a high or indeterminate risk of bias (23/24 models). The added value of intra-operative variables was assessed in six studies with statistically significantly improved discrimination demonstrated in two.ConclusionWeak reporting and methodological limitations may restrict wider applicability and adoption of existing CPMs that include intra-operative variables. There is some evidence that CPM discrimination is improved with the addition of intra-operative variables. Further work is required to understand the role of intra-operative CPMs in the management of cardiac surgery patients.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140636121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-22DOI: 10.1177/02676591241246080
Kirti P Patel, Alfred H Stammers, Eric A Tesdahl, Jeffrey Chores, Scott R Beckmann, Jennifer Baeza, Craig M Petterson, Ty Thompson, Alexander Baginski, Michael Firstenberg, Jeffrey P Jacobs
{"title":"Effect of geography on the use of ultrafiltration during cardiac surgery with cardiopulmonary bypass","authors":"Kirti P Patel, Alfred H Stammers, Eric A Tesdahl, Jeffrey Chores, Scott R Beckmann, Jennifer Baeza, Craig M Petterson, Ty Thompson, Alexander Baginski, Michael Firstenberg, Jeffrey P Jacobs","doi":"10.1177/02676591241246080","DOIUrl":"https://doi.org/10.1177/02676591241246080","url":null,"abstract":"BackgroundUltrafiltration (UF) is a common practice during cardiopulmonary bypass (CPB) where it is used as a blood management strategy to reduce red blood cell (RBC) transfusion, minimize adverse effects of hemodilution, and reduce proinflammatory mediators. However, its clinical utilization has been shown to vary throughout the continents.PurposeThe purpose of this investigation was to assess the distribution of UF use across the United States.Data CollectionData on UF use during cardiac surgery was obtained from a national (United States) perfusion database for adult cardiac procedures performed from January 2016 through December 2018.Study SampleFour geographical regions were established: Northeast (NE), South (SO), Midwest (MW) and West (WE). The primary endpoint was the use of UF with secondary endpoints UF volume, CPB and anesthesia asanguineous volumes, intraoperative allogeneic RBC transfusion, nadir hematocrit and urine output (UO). 92,859 adult cardiac cases from 191 hospitals were reviewed.ResultsThe NE and the WE had similar usages of UF (59.9% and 59.7% respectively), which were higher than the MW and the SO (38.6% and 34.9%, p < .001). When UF was utilized, the median [IQR] volume removed was highest in the NE (1900 [1200-2800]mL), and similar in all other regions (WE 1500 [850-2400 mL, MW 1500 [900-2300]mL and SO 1500 [950-2200]mL, p < .001. Median total UO was lowest in the NE 400 [210,650]mL vs all other regions ( p < .001), and remained so when indexed by patient weight and operative time (NE-0.8 [0.5, 1.3]mL/kg/hour, MW-1.1 [0.7, 1.8] mL/kg/hour, SO-1.3 [0.8, 2.0]mL/kg/hour, WE-1.1 [0.7, 1.3]mL/kg/hour, p < .001. Intraoperative RBC transfusion rate was highest in the SO (21.3%) and WE (20.5%), while similar rates seen in the NE (16.2%) and MW (17.6%), p < .001.ConclusionsAcross the United States there is geographic variation on the use of UF. Further research is warranted to investigate why these practice variations exist and to better understand and determine their reasons for use.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140635868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-22DOI: 10.1177/02676591241248539
Christian Klüß, André Giesbrecht, Markus Rudloff, Vera von Dossow, Eugen Sandica, Jan Gummert
{"title":"Practical training concept for perfusionists at the heart and diabetes center Nordrhein-Westfalen","authors":"Christian Klüß, André Giesbrecht, Markus Rudloff, Vera von Dossow, Eugen Sandica, Jan Gummert","doi":"10.1177/02676591241248539","DOIUrl":"https://doi.org/10.1177/02676591241248539","url":null,"abstract":"BackgroundIncreasing regulations and requirements of advisory bodies, in particular the Joint Federal Committee and the Medical Service of the health insurance funds, make it necessary to employ only demonstrably well-trained perfusionists. The minimum requirement for this staff is EBCP certification. Currently there is limited availability of such specialists on the German market. Therefore, the qualification of young people in this area is of central importance. The aim of this paper is to strengthen the training of perfusionists at our centre, to standardise the process and to provide the respective student with a “roadmap” to their internship.Material & MethodsThe structure is based on a rough division of the 24 weeks of internship. This is described in detail in the following and is backed up with the learning objectives for the respective time periods.ResultsAt our centre, practical training has been standardized and clear responsibilities have been defined. Furthermore, as a centre of maximum care in the field of cardiac surgery, we can offer students the necessary number of perfusions in just six months to meet the requirements of the ECBP for practical training. According to this concept, 20 perfusionists have been successfully trained in the last 8 years. All of them have passed the exams and have been certified according to EBCP.ConclusionThe aim of the practical semester is for the student to be in a position at the end of the semester to independently supervise simple cardiac surgery procedures with the aid of the Extra- Corporal Circulation (ECC) and to carry this out in accordance with the currently valid guidelines and directives (1–8) and the departmental procedural instructions based on them. Great emphasis is placed to the students becoming aware of their competence to act, knowing their limits and being able to assess when these limits have been reached and the involvement of experienced colleagues is necessary to ensure patient safety.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140636176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-17DOI: 10.1177/02676591241247294
Mohammed Alsagheer Alhewy, Ibrahim Hanbal Hanbal, Abdelaziz Ahmed Abdelhafez, Mohamed Hamza Metwaly, Abdelhalim A Abdelmohsen, Ehab Abd elmoneim Ghazala, Alhussein M Khedr, Ahmed Atef Khamis, Hassan Gado, Wael Abdo Abdo Abd-Elgawad, Abdullah El Sayed, Awad Ibrahim, Yasser Elghoneimy, Sameh E Elimam
{"title":"The outcome of endovenous intervention for acute iliofemoral deep venous thrombosis with and without inferior vena cava filter","authors":"Mohammed Alsagheer Alhewy, Ibrahim Hanbal Hanbal, Abdelaziz Ahmed Abdelhafez, Mohamed Hamza Metwaly, Abdelhalim A Abdelmohsen, Ehab Abd elmoneim Ghazala, Alhussein M Khedr, Ahmed Atef Khamis, Hassan Gado, Wael Abdo Abdo Abd-Elgawad, Abdullah El Sayed, Awad Ibrahim, Yasser Elghoneimy, Sameh E Elimam","doi":"10.1177/02676591241247294","DOIUrl":"https://doi.org/10.1177/02676591241247294","url":null,"abstract":"BackgroundCatheter-directed thrombolysis (CDT) for acute iliofemoral deep venous thrombosis (DVT) is an endovenous interventional therapy that can quickly remove the acute thrombus, thereby improving the clinical outcomes of proximal DVT. However, instrumentation of extensive fresh thrombus may be associated with iatrogenic pulmonary embolism (PE). Therefore, we aimed to compare CDT’s safety, complications, and perioperative embolic (PE) insults for acute iliofemoral DVT, with and without an IVC filter.MethodsOne hundred twenty patients having acute proximal DVT for less than 14 days and undergoing endovenous therapy were included and presented to the vascular surgery department of Al-Azhar University Hospitals, Egypt. The patients were randomized into two equal groups, Groups A and B, each having 60 patients. Group A was treated with IVC filter insertion, while Group B was treated without a filter. The anticoagulation and CDT procedures were similar between the two groups.ResultsThe sample included 96 females (80%) and 24 males (20%), with a mean age of 32.6 ± 7.2 years. Clinically no clinical PE occurred in both groups. However, radiologically, new lesions in multislice CT pulmonary angiogram and V/Q scan were noted in two of 60 patients (3.33%) of the IVC filter group, compared with three patients (5 %) in the non-filtered group.ConclusionEndovenous intervention in the form of CDT for acute iliofemoral DVT without an IVC filter is safe and not associated with an increased risk of pulmonary embolization than filter usage. The routine use of IVC filters should not be used mandatorily during CDT.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"163 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140609548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-16DOI: 10.1177/02676591241247981
Sonia Labarinas, Kalpana Norbisrath, Dana Johnson, Jon Meliones, Christopher Greenleaf, Jorge Salazar, Oliver Karam
{"title":"Clinical outcomes in critically ill children on extracorporeal membrane oxygenation with severe thrombocytopenia","authors":"Sonia Labarinas, Kalpana Norbisrath, Dana Johnson, Jon Meliones, Christopher Greenleaf, Jorge Salazar, Oliver Karam","doi":"10.1177/02676591241247981","DOIUrl":"https://doi.org/10.1177/02676591241247981","url":null,"abstract":"IntroductionAs international guidelines suggest keeping the platelet count between 50 and 100 × 10<jats:sup>9</jats:sup> cells/L in children on extracorporeal membrane oxygenation (ECMO), platelet transfusions are administered to two-thirds of ECMO days, and up to 70% of these patients still bleed. We aim to describe outcomes in critically ill children who develop severe thrombocytopenia on ECMO.MethodsSingle-center retrospective study, enrolling critically ill children on ECMO admitted at Children’s Memorial Hermann, TX, between 1/2018 and 12/2022, with at least one platelet count below 50 × 10<jats:sup>9</jats:sup> cells/L (severe thrombocytopenia). Platelet counts were measured four times a day. We report platelet transfusion, bleeding, hemolysis, and clotting events within 6 h after transfusion, as well as ECMO duration and mortality.ResultsWe enrolled 54 patients representing 337 ECMO days and 1190 platelet counts. Median weight was 3.7 kg and 54% were male. Severe thrombocytopenia was observed in 56% of platelet counts. Severe thrombocytopenia was not associated with bleeding in the subsequent 6 h (18% vs 20%, p = .95), but was associated with more frequent platelet transfusions (18% vs 11%, p = .001). There was no correlation between time spent with severe thrombocytopenia and the duration of ECMO (R<jats:sup>2</jats:sup> = 0.03). While the time spent with severe thrombocytopenia was not associated with on-ECMO mortality rate ( p = .36), there was an association with in-hospital mortality rate ( p = .003).ConclusionsOur results indicate a restrictive platelet transfusion strategy is not associated with higher proportions of subsequent bleeding, duration of ECMO, or on-ECMO mortality rate. Multicenter studies are needed to evaluate further the appropriateness of this strategy.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"96 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140609478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-16DOI: 10.1177/02676591241247977
Despoina G Sarridou, Anna Gkiouliava, Helena Argiriadou, Sophia Anastasia Mouratoglou, Jeremy B Mitchell, Christopher P Walker
{"title":"Perioperative management of a double valve replacement and coronary artery bypass graft in a patient with carcinoid syndrome; a case report and literature review","authors":"Despoina G Sarridou, Anna Gkiouliava, Helena Argiriadou, Sophia Anastasia Mouratoglou, Jeremy B Mitchell, Christopher P Walker","doi":"10.1177/02676591241247977","DOIUrl":"https://doi.org/10.1177/02676591241247977","url":null,"abstract":"IntroductionCarcinoid tumors are rare neuroendocrine tumors; about 5% of patients develop the carcinoid syndrome. We present the case of a patient with carcinoid syndrome undergoing cardiac surgery.Case reportA 74-year-old patient with carcinoid heart disease and hepatic metastases underwent double valve replacement and CABG. The patient was on octreotide therapy and antihypertensive medication. An octreotide infusion was commenced perioperatively. Pharmaceutical agents that could potentially precipitate histamine release or exacerbate catecholamine secretion and carcinoid crises were avoided. Postoperatively, recovery was complicated by atrial fibrillation, chest infection, pleural effusions, acute kidney injury and delirium.DiscussionHepatic metastases cause systemic hormones’ secretion, which cause a carcinoid crisis. Perioperative administration of octreotide is used, while vigilance is required to differentiate between hemodynamic effects related to the operation or disease specific factors.ConclusionNo carcinoid crisis was evident perioperatively. High vigilance with appropriate monitoring, aggressive management combined with meticulous choice of pharmaceutical agents led to this outcome.","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140609473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PerfusionPub Date : 2024-04-16DOI: 10.1177/02676591241240299
{"title":"Correction to ‘corrigendum to “Microplegia in paediatric hearts”’","authors":"","doi":"10.1177/02676591241240299","DOIUrl":"https://doi.org/10.1177/02676591241240299","url":null,"abstract":"","PeriodicalId":519219,"journal":{"name":"Perfusion","volume":"301 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140609327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}